Dublin Medical (DM), a large established corporation with no growth in its real earnings, is considering acquiring 100% of the shares of Arlington Corporation, a young firm with a high growth rate of earnings. The acquisitions analysis group at DM has produced the following table of relevant data:

Dublin Medical Arlington

Earnings   per   share   $3.00 $2.00 

Dividend   per   share   $3.00   $.80 

Number   of   shares   200   million 10   million 

Stock   price   $30 $20 

Analysts estimate that investors currently expect growth of about 6% per year in Arlington's earnings and dividends. They assume that with the improvements in management that DM could bring to Arlington; its growth rate would be 10% per year beginning one year from now with no additional investment outlays beyond those already expected.

Question

1) What is the expected gain from acquisition?

2) What is the NPV of the acquisition to DM shareholders if it cost an average $30/per share to acquire all the outstanding shares?

3) Would it matter to DM's shareholders whether the shares of Arlington stock are acquired by paying cash or DM stock?